Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
'Oncometabolite' Linked to Onset of Acute Myeloid Leukemia | |
|
| |
Scientists have identified a causative link between the product of a mutated metabolic enzyme and the onset of acute myeloid leukemia (AML). Called an "oncometabolite" for its role in cancer metabolism, the metabolite2-hydroxyglutarate (2HG) is a by-product of a gene mutation of an enzyme known as isocitrate dehydrogenase (IDH).
Says Dr. Tak Mak of the findings published today in Nature: "For the first time, we have demonstrated how a metabolite can cause cancer. This sets the stage for developing inhibitors to block the mutation and prevent the production of this disease-initiating enzyme." The research team included scientists at Weill Cornell Medical College, New York City, and Agios Pharmaceuticals, Cambridge, Massachusetts.
Dr. Mak, Director, The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, is an internationally acclaimed immunologist renowned for his 1984 discovery of cloning the human T-cell receptor. He is also Professor, University of Toronto, in the Departments of Medical Biophysics and Immunology.
The connection between cancer and metabolism has fascinated scientists at Agios and Dr. Mak, who were the first to identify the oncometabolite in research published in Nature (2009) and The Journal of Experimental Medicine (2010). The IDH gene mutation was initially discovered in brain cancers in 2008 by American scientists at Johns Hopkins in Baltimore and subsequently also linked to leukemia.
In the lab, Dr. Mak's team genetically engineered a mouse model with the mutation in its blood system to mimic human AML. They discovered that the gene mutation launches the perfect storm for the oncometabolite to trigger the blood system to increase the stem cells pool and reduce mature blood cells in the bone marrow. The resulting condition creates a situation with similarities to myelodysplastic syndrome - one of the precursors to this type of leukemia.
"This is one of the most common mutations in AML," says Dr. Mak. "We also found that it is the common mutation in about 40% of a specific type of lymphoma." The mutation is also known to be involved in about 70-90% of low-grade brain cancers (glioblastomas gliomas) and a variety of other cancers.
Dr. Mak's interest in the blood system began as a young researcher three decades ago with Drs. Ernest McCulloch and James Till, the acclaimed "fathers of stem cell science" at Ontario Cancer Institute, the research arm of Princess Margaret Hospital, whose 1961 discovery of stem cells launched the new field.
Source-Eurekalert
| |
|
|
More News on: Leukemia, Chronic Myeloid Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Multiple Myeloma, Bone Marrow Transplantation, Leukemia
 Comment & Contribute
|
Related Links
Acute Myeloid Leukemia
Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukemia that affects both children and adults ...
Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by excess of WBC stem cells in the bone ...
New Drug Combination Promises Better Treatment Outcomes in Chronic Myeloid Leukemia (CML)
Treatment with Imatinib and Peginterferon alfa-2a is associated with significantly higher rates of molecular responses in people with Chronic ...
Gene FLT3 Valid Target in Acute Myeloid Leukemia Treatment
A group of American researchers have found that gene FLT3 can be a valid target in treating one of the most common forms of leukemia called the Acute ...
Cancer Related News
Study: 2 Radiotherapy Treatments Show Similar Morbidity, Cancer Control After Prostatectomy
According to a study, use of the newer, more expensive intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) ...
Research: The Compound in the Mediterranean Diet That Makes Cancer Cells 'Mortal'
A compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death, suggests new research. By ...
IMRT may Not be More Effective Than Older Radiation Techniques After Prostatectomy: Research
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer. Despite this, research from the ...
Study Says Grapefruit Nanoparticles can Deliver Anti-cancer Drugs
Engineered nanoparticles derived from grapefruit can be used to deliver anti-cancer and other drugs to tumor cells, say researchers. ...
India Gets Advanced Breast Cancer Detecting Machine
In the national capital, an advanced digital breast cancer detecting machine with the capability to see the lesions in breasts with much more clarity ...
New Method can Help Distinguish Pancreatic Cancer from Pancreatitis
In a promising development that could help improve the accuracy of pancreatic cancer diagnosis, researchers at Mayo Clinic have come up with a new ...
- Health News Index
 | Quiz on Leukemia Making up for 2.9% of all cancers, Leukemia is a serious condition. Do you know all about it? Test your knowledge with this quiz. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Leukemia
Complete Medindia Resources
|
| News Categories: |
| » | Health Care Costs can be Reduced by ER Docs |
| » | Hospital Use and Costs Not Increased by Massachusetts' Health Care Reform |
| » | Preparation on for Health Care Revamping |
| » | Federal Spending to Treat Chronic Pain Should be a Top Healthcare Priority |
| » | Obama Campaigns to Advance Health Care Program |
| More Insurance News | |
|
Ask an Expert
